Pine Pharmaceuticals, LLC: Bevacizumab 1.25 MG/0.05 ML Solution for Injection, 1 mL syringes, Rx only, Compounded by Pine Pharmaceuticals 355 Riverwalk Parkway, Tonawanda, NY 14150.

Hazard

Lack of Assurance of Sterility

Details from the source

Reason for recall: Lack of Assurance of Sterility Distribution: Nationwide within the United States Quantity: 2862 Syringes Lot/code info: Lot #: 68622, 68620 Exp. Date 10/3/2023; 68632 Exp. Date 10/4/2023; 68699, 68704, 68706 Exp. Date 10/6/2023; 68726, 68740 Exp. Date 10/7/2023; 68784 Exp. Date 10/11/2023; 68843, 68861, Exp. Date 10/13/2023; 68789,68822 Exp. Date 10/12/2023; 68914 Exp. Date 10/17/2023; 68952, 68954, 68980 Exp. Date 10/18/2023; 69105 Exp. Date 10/25/2023; 69731 Exp. Date 11/7/2023; 69991 Exp. Date 11/15/2023;70142 Exp. Date 11/22/2023; 70233 Exp. Date 11/28/2023; 70297, 70264, 70291, 70300 Exp. Date 11/30/2023; 70355 Exp. Date 12/5/2023; 70516, 70513 Exp. Date 12/12/2023;;70659, 70664 Exp. Date 12/19/2023; 70700 Exp. Date 12/20/2023; 68912, Exp. Date 10/17/2023; 69071, Exp. Date 10/24/2023; 69725, Exp. Date 10/31/2023; 69749, Exp. Date 11/1/2023; 69961, Exp. Date 11/14/2023; 70112, Exp. Date 11/21/2023; 70228, Exp. Date 11/28/2023; 70353, Exp. Date 12/5/2023; 70403, Exp. Date 12/9/2023; 70513, Exp. Date 2/12/2023; 70569, 70570, 70579, 70571, 70572,70573, 70585, 70503 Exp. Date 12/14/2023; 70692, Exp. Date 12/20/2023; 68912, Exp. Date 10/17/2023; 69071, Exp. Date 10/24/2023; 69725, Exp. Date 10/31/2023; 69749, Exp. Date 1/7/2023; 69961, Exp. Date 11/14/2023; 70112, Exp. Date 11/21/2023; 70228, Exp. Date 11/28/2023; 70353, Exp. Date 12/5/2023; 70 692, Exp. Date 12/20/2023, 67538, Exp. Date 10/11/2023; 68535, Exp. Date 10/4/2023; 68611, 68613 Exp. Date 10/3/2023; 68612, 68633, 68637 Exp. Date 10/4/2023; 68638, 68673, 68674,68675, Exp. Date 10/5/2023; 68634, 68699, 68700, 68701, 68702, 68709 Exp. D

Source

Official record: FDA (Drug enforcement) ↗

Republished from the official source above; details can change — the source record controls.